Cinven is reviewing strategic options for laboratory-services company Synlab International GmbH including a potential sale, people with knowledge of the matter said.
The private equity firm has been speaking with potential advisers and could start a sale process early next year, the people said, asking not to be identified because the information is private. Cinven plans to seek a valuation of about 5.5 billion euros ($6 billion) including debt for Augsburg, Germany-based Synlab, one of the people said.
A sale of Synlab would likely attract other private equity firms, the people said. No final decision has been made, and Cinven could elect to keep the business, the people said. A spokeswoman for Cinven declined to comment, while Synlab didn’t answer phone calls seeking comment.
Cinven first invested in Synlab in June 2015, buying a majority stake from fellow private equity firm BC Partners for about 1.7 billion euros, Bloomberg News reported at the time. It combined the business with Labco SA, which it agreed to buy earlier that year for 1.2 billion euros.
Synlab, led by Chief Executive Officer Mathieu Floreani, also counts Novo A/S and Ontario Teachers’ Pension Plan as minority investors, according to its website. It operates across more than 40 countries, handling more than 500 million clinical tests annually, according to Synlab’s website.
Cinven also owns stakes in retailer Kurt Geiger and German drugmaker Stada Arzneimittel AG, according to its website.
The sale plan comes at a time when Cinven’s rival Apax Partners is also weighing a sale of diagnostic services business Unilabs. The buyout firm is working with advisers at Rothschild & Co. to look at options for the business, people familiar with the matter said last week.
Source: Bloomberg
Can’t stop reading? Read more
JPMorgan begins private lending drive with $10bn
JPMorgan Chase & Co has set aside at least $10 billion to back its foray into the world of direct lending. The Wall Street titan's move into the market is likely to put it head to head with established sector heavyweights such as Ares Management Corp and Apollo...
Pollen Street Capital to buy Mattioli Woods in £423m take
Mattioli Woods looks set to be sold in a £432m deal to private equity firm Pollen Street Capital. The deal will see Leicester-based Mattioli Woods investors receive 804p for each share they hold. The firm’s directors have recommended that shareholders vote through the...
Modern Wealth Management acquires $1.2bn retirement shop
Modern Wealth Management, an American registered investment advisory (RIA), has snapped up Beltz Ianni & Associates (Beltz Ianni) for an undisclosed price, in a move to expand its footprint to the eastern region of the US. Beltz Ianni, which is based in Rochester,...